INS and Hypoglycemia: In conclusion, in patients with type 1 and type 2 DM, switching to insulin degludec offered better glycemic control, which was manifested by a reduction in HbA1c levels, a reduction in insulin dose, and no increase in the frequency of reported hypoglycemia in this Saudi Arabian population.